-
公开(公告)号:US20060205692A1
公开(公告)日:2006-09-14
申请号:US10513552
申请日:2003-05-09
申请人: Imber Montes , Hieu Pham , Lan Nguyen , Vinh Diep , Emanuele Burattini , Carlo Severi , Eric Neisor , Anne Perez , Jean-Luc Thuillard , Yves Guyon-Gellin , Craig Bentzen
发明人: Imber Montes , Hieu Pham , Lan Nguyen , Vinh Diep , Emanuele Burattini , Carlo Severi , Eric Neisor , Anne Perez , Jean-Luc Thuillard , Yves Guyon-Gellin , Craig Bentzen
IPC分类号: A61K31/675 , A61K31/663 , C07F9/58 , C07F9/572 , C07F9/28
CPC分类号: C07F9/404 , C07F9/4025 , C07F9/572 , C07F9/5728 , C07F9/5765 , C07F9/58 , C07F9/59 , C07F9/6533
摘要: The present invention relates to methods of use 1,1- and 1,2-bisphosphonate compounds to modulate apolipoprotein E levels and use of such compounds in therapy, including cardiovascular and neurological disease states.
摘要翻译: 本发明涉及使用1,1-和1,2-二膦酸盐化合物调节载脂蛋白E水平和在治疗中使用这些化合物的方法,包括心血管和神经疾病状态。